New hope for advanced bile duct cancer patients with rare gene mutation
NCT ID NCT04507503
First seen Mar 18, 2026 · Last updated May 07, 2026 · Updated 9 times
Summary
This program gives patients with advanced bile duct cancer that has a specific FGFR2 gene change access to the drug futibatinib. It is for people who have tried standard treatments without success or cannot tolerate them. The goal is to provide a treatment option when others have failed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advent Health Orlando
Orlando, Florida, 32804, United States
-
Aurora Cancer care
Grafton, Wisconsin, 53024, United States
-
Banner MD Anderson
Gilbert, Arizona, 85234, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
MD Anderson
Houston, Texas, 77030, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mount Sinai Center of Florida
Miami Beach, Florida, 33140, United States
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231, United States
-
UCLA Division of Hematology-Oncology
Santa Monica, California, 90404, United States
-
University of California, San Francisco (UCSF)
San Francisco, California, 94143, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Kansas Cancer Center
Lee's Summit, Missouri, 64064, United States
-
Utah Cancer Specialists
Salt Lake City, Utah, 84106, United States
Conditions
Explore the condition pages connected to this study.